AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 146 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $46 | -16.4% | 50,633 | -48.3% | 0.00% | -33.3% |
| Q1 2023 | $55 | -99.9% | 97,854 | -25.3% | 0.01% | -14.3% |
| Q1 2022 | $94,000 | -46.3% | 130,949 | +183.0% | 0.01% | -58.8% |
| Q2 2021 | $175,000 | -68.4% | 46,270 | -71.7% | 0.02% | -56.4% |
| Q1 2021 | $554,000 | +167.6% | 163,532 | +98.7% | 0.04% | +8.3% |
| Q3 2020 | $207,000 | +68.3% | 82,303 | +322.3% | 0.04% | +200.0% |
| Q4 2019 | $123,000 | +66.2% | 19,491 | +2.9% | 0.01% | +100.0% |
| Q3 2019 | $74,000 | -52.6% | 18,948 | -32.8% | 0.01% | -25.0% |
| Q4 2018 | $156,000 | +54.5% | 28,181 | +179.1% | 0.01% | +100.0% |
| Q2 2018 | $101,000 | -54.7% | 10,097 | -56.8% | 0.00% | -66.7% |
| Q1 2018 | $223,000 | +21.2% | 23,352 | +88.5% | 0.01% | +20.0% |
| Q4 2017 | $184,000 | -9.8% | 12,387 | +19.4% | 0.01% | 0.0% |
| Q3 2017 | $204,000 | – | 10,372 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |